X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-05-30 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale | $110.17 | -2,000 | 18,634 | -10% | -$220,330 | ||||||
2024-05-28 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $109.96 | -1,647 | 114,186 | -1% | -$181,103 | ||||||
2024-05-28 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $109.96 | -1,438 | 109,940 | -1% | -$158,122 | ||||||
2024-05-28 | NTRA | Natera, Inc. | Chapman Rowan E | Dir | S - Sale | $109.09 | -4,856 | 5,005 | -49% | -$529,728 | ||||||
2024-05-28 | VCYT | Veracyte, Inc. | Bhanji Muna | Dir | S - Sale | $21.00 | -1,539 | 26,975 | -5% | -$32,319 | ||||||
2024-05-29 | FTRE | Fortrea Holdings Inc. | Pike Thomas | CEO | P - Purchase | $24.81 | +10,000 | 57,827 | +21% | +$248,066 | ||||||
2024-05-23 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $108.30 | -1,000 | 444,372 | 0% | -$108,301 | ||||||
2024-05-17 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $1.38 | -940 | 132,806 | -1% | -$1,297 | ||||||
2024-05-17 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $1.38 | -1,333 | 183,188 | -1% | -$1,840 | ||||||
2024-05-17 | PSNL | Personalis, Inc. | Moore Stephen Michael | SVP, GC | S - Sale | $1.38 | -1,731 | 70,666 | -2% | -$2,389 | ||||||
2024-05-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $107.08 | -6,779 | 219,456 | -3% | -$725,911 | ||||||
2024-05-16 | XGN | Exagen Inc. | Aballi John | Pres, CEO | P - Purchase | $1.92 | +40,401 | 641,189 | +7% | +$77,570 | ||||||
2024-05-14 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $24.27 | -6,336 | 401,192 | -2% | -$153,753 | ||||||
2024-05-14 | LH | Laboratory Corp of America Holdings | Van Der Vaart Sandra D | EVP, GC | S - Sale | $210.83 | -2,000 | 5,637 | -26% | -$421,655 | ||||||
2024-05-15 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $8.24 | -10,387 | 185,300 | -5% | -$85,589 | ||||||
| D | 2024-05-10 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $104.59 | -30,000 | 204,495 | -13% | -$3,137,567 | |||||
2024-05-10 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $105.11 | -2,700 | 457,225 | -1% | -$283,794 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $9.59 | -4,205 | 154,833 | -3% | -$40,326 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $9.59 | -4,902 | 134,869 | -4% | -$47,010 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $9.59 | -4,902 | 145,277 | -3% | -$47,010 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $9.59 | -6,592 | 315,896 | -2% | -$63,217 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $9.59 | -11,992 | 896,112 | -1% | -$115,003 | ||||||
2024-05-08 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $9.59 | -4,902 | 140,795 | -3% | -$47,010 | ||||||
| D | 2024-05-09 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $1.48 | -244 | 9,915 | -2% | -$361 | |||||
| D | 2024-05-09 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $1.48 | -434 | 124,248 | 0% | -$642 | |||||
| D | 2024-05-09 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $1.48 | -468 | 75,524 | -1% | -$692 | |||||
| D | 2024-05-09 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $1.48 | -3,764 | 483,780 | -1% | -$5,569 | |||||
| D | 2024-05-09 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $1.48 | -980 | 171,680 | -1% | -$1,450 | |||||
2024-05-06 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $24.64 | -23,323 | 59,740 | -28% | -$574,679 | ||||||
2024-05-06 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $24.72 | -6,336 | 407,528 | -2% | -$156,626 | ||||||
2024-05-01 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $93.97 | -1,866 | 67,542 | -3% | -$175,344 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Coward D Scott | Dir | S - Sale | $60.15 | -67 | 49,337 | 0% | -$4,030 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Cunningham Everett | Chief Commercial Officer | S - Sale | $60.15 | -136 | 47,613 | 0% | -$8,180 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Herriott James | SVP, GC, Sec | S - Sale | $60.15 | -30 | 11,049 | 0% | -$1,805 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Elliott Jeffrey Thomas | CFO | S - Sale | $60.15 | -136 | 13,380 | -1% | -$8,180 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Baranick Brian | EVP, GM., Precision Oncology | S - Sale | $60.15 | -110 | 13,733 | -1% | -$6,617 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale | $60.15 | -102 | 78,337 | 0% | -$6,135 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Orville Jacob A | GM, Screening | S - Sale | $60.15 | -102 | 15,557 | -1% | -$6,135 | ||||||
2024-05-01 | EXAS | Exact Sciences Corp | Conroy Kevin T | Pres, CEO | S - Sale | $60.15 | -1,155 | 1,394,770 | 0% | -$69,473 | ||||||
2024-04-30 | PSNL | Personalis, Inc. | Moore Stephen Michael | SVP, GC | S - Sale | $1.37 | -4,523 | 72,397 | -6% | -$6,197 | ||||||
| M | 2024-04-30 | LH | Laboratory Corp of America Holdings | Anderson Kerrii B | Dir | S - Sale | $202.12 | -500 | 16,010 | -3% | -$101,058 | |||||
2024-04-29 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $93.14 | -929 | 110,748 | -1% | -$86,526 | ||||||
2024-04-29 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $93.14 | -1,196 | 115,833 | -1% | -$111,394 | ||||||
2024-04-29 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $93.14 | -1,057 | 204,495 | -1% | -$98,448 | ||||||
2024-04-29 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $93.14 | -4,084 | 226,235 | -2% | -$380,378 | ||||||
2024-04-29 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $93.14 | -1,238 | 69,408 | -2% | -$115,306 | ||||||
2024-04-29 | LH | Laboratory Corp of America Holdings | Wilkinson Peter J | SVP, Chief Accounting Officer | S - Sale | $204.33 | -2,439 | 2,087 | -54% | -$498,358 | ||||||
2024-04-29 | DGX | Quest Diagnostics Inc | Kuppusamy Karthik | SVP, Clinical Solutions | S - Sale | $140.00 | -1,760 | 15,344 | -10% | -$246,400 | ||||||
2024-04-25 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $89.55 | -1,000 | 459,528 | 0% | -$89,550 | ||||||
| M | 2024-04-24 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $91.67 | -2,393 | 70,646 | -3% | -$219,365 | |||||
| D | 2024-04-24 | CELC | Celcuity Inc. | Buller Richard E | Dir | S - Sale+OE | $17.06 | -350 | 7,731 | -4% | -$5,971 | |||||
2024-04-23 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.11 | -1,126 | 413,864 | 0% | -$22,643 | ||||||
| D | 2024-04-23 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $91.38 | -787 | 205,552 | 0% | -$71,915 | |||||
2024-04-23 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $91.38 | -531 | 117,029 | 0% | -$48,522 | ||||||
2024-04-23 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $91.38 | -522 | 111,677 | 0% | -$47,700 | ||||||
| D | 2024-04-23 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $91.38 | -2,552 | 230,319 | -1% | -$233,200 | |||||
| D | 2024-04-23 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $91.38 | -1,523 | 73,039 | -2% | -$139,171 | |||||
2024-04-16 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $90.82 | -80,000 | 117,560 | -40% | -$7,265,651 | ||||||
2024-04-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $93.13 | -6,816 | 227,710 | -3% | -$634,797 | ||||||
2024-04-12 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.35 | -5,210 | 414,990 | -1% | -$106,024 | ||||||
2024-04-08 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $20.45 | -2,400 | 83,063 | -3% | -$49,087 | ||||||
| M | 2024-04-04 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $21.12 | -20,923 | 85,463 | -20% | -$441,853 | |||||
2024-04-03 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $21.70 | -6,336 | 420,200 | -1% | -$137,491 | ||||||
2024-04-03 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $92.47 | -26,700 | 460,195 | -5% | -$2,468,822 | ||||||
2024-04-02 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $92.62 | -1,378 | 70,646 | -2% | -$127,629 | ||||||
2024-04-01 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale | $70.00 | -2,000 | 77,513 | -3% | -$140,000 | ||||||
2024-04-02 | EXAS | Exact Sciences Corp | Baranick Brian | EVP, GM., Precision Oncology | S - Sale | $79.43 | -924 | 13,625 | -6% | -$73,393 | ||||||
2024-04-01 | LH | Laboratory Corp of America Holdings | Schroeder Mark S | EVP, Pres Diagnostics, COO | S - Sale | $217.29 | -6,477 | 5,036 | -56% | -$1,407,387 | ||||||
2024-04-01 | LH | Laboratory Corp of America Holdings | Summy Amy B. | EVP, CMO | S - Sale | $217.29 | -3,500 | 3,975 | -47% | -$760,515 | ||||||
| D | 2024-04-01 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale+OE | $21.65 | -10,000 | 33,125 | -23% | -$216,528 | |||||
2024-03-28 | EXAS | Exact Sciences Corp | Condella Sarah | EVP, HR | S - Sale | $70.00 | -2,000 | 79,513 | -2% | -$140,000 | ||||||
| D | 2024-03-28 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $90.16 | -1,447 | 486,895 | 0% | -$130,456 | |||||
| D | 2024-03-28 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $90.42 | -743 | 204,839 | 0% | -$67,179 | |||||
2024-03-28 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $90.42 | -707 | 197,560 | 0% | -$63,924 | ||||||
2024-03-28 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $90.42 | -464 | 112,199 | 0% | -$41,953 | ||||||
| DM | 2024-03-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $89.09 | -53,572 | 234,526 | -19% | -$4,772,752 | |||||
| D | 2024-03-28 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $90.42 | -914 | 72,024 | -1% | -$82,640 | |||||
| D | 2024-03-28 | LH | Laboratory Corp of America Holdings | Van Der Vaart Sandra D | EVP, GC | S - Sale+OE | $216.74 | -3,553 | 7,637 | -32% | -$770,077 | |||||
| DM | 2024-03-27 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale+OE | $9.44 | -77,136 | 139,771 | -36% | -$727,853 | |||||
2024-03-26 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $9.37 | -38,899 | 908,104 | -4% | -$364,484 | ||||||
2024-03-26 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $9.37 | -8,092 | 322,488 | -2% | -$75,822 | ||||||
2024-03-26 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $9.55 | -21,438 | 143,524 | -13% | -$204,733 | ||||||
2024-03-25 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $9.10 | -22,163 | 164,962 | -12% | -$201,683 | ||||||
| M | 2024-03-20 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.28 | -6,336 | 426,536 | -1% | -$128,514 | |||||
2024-03-18 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | P - Purchase | $17.82 | +2,187 | 12,722 | +21% | +$38,963 | ||||||
| D | 2024-03-15 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $88.96 | -83,223 | 282,914 | -23% | -$7,403,534 | |||||
2024-03-07 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.77 | -6,368 | 432,872 | -1% | -$132,263 | ||||||
| D | 2024-03-07 | LH | Laboratory Corp of America Holdings | Schroeder Mark S | EVP, Pres Diagnostics, COO | S - Sale+OE | $218.45 | -5,048 | 5,036 | -50% | -$1,102,736 | |||||
2024-03-07 | LH | Laboratory Corp of America Holdings | Summy Amy B. | EVP, CMO | S - Sale | $218.45 | -227 | 3,859 | -6% | -$49,588 | ||||||
| M | 2024-03-05 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $88.64 | -6,028 | 487,895 | -1% | -$534,331 | |||||
2024-03-05 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $88.37 | -2,160 | 204,218 | -1% | -$190,868 | ||||||
2024-03-05 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $88.37 | -9,326 | 297,867 | -3% | -$824,092 | ||||||
2024-03-05 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $88.37 | -2,826 | 70,646 | -4% | -$249,719 | ||||||
2024-03-05 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $88.36 | -2,245 | 198,267 | -1% | -$198,361 | ||||||
2024-03-05 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $88.36 | -1,838 | 112,663 | -2% | -$162,400 | ||||||
2024-03-05 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $87.40 | -191,012 | 1,935,684 | -9% | -$16,694,485 | ||||||
2024-03-06 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $9.02 | -1,664 | 187,125 | -1% | -$15,009 | ||||||
2024-03-06 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $9.02 | -444 | 330,580 | 0% | -$4,005 | ||||||
2024-03-06 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $9.02 | -1,028 | 159,038 | -1% | -$9,273 | ||||||
2024-03-06 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $9.02 | -2,138 | 145,697 | -1% | -$19,285 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |